|
Volumn 85, Issue 6, 2000, Pages 2215-2222
|
Endocrine consequences of long-term intrathecal administration of opioids
a,e b c d b a a a b a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANDROGEN;
ESTRADIOL;
ESTROGEN;
FOLLITROPIN;
GESTAGEN;
HIGH DENSITY LIPOPROTEIN CHOLESTEROL;
HYDROCORTISONE;
HYDROMORPHONE;
LUTEINIZING HORMONE;
MORPHINE;
OPIATE AGONIST;
PROGESTERONE;
SOMATOMEDIN C;
TESTOSTERONE;
ADULT;
AGED;
AMENORRHEA;
ANDROGEN BLOOD LEVEL;
ARTICLE;
CONTROLLED STUDY;
ESTRADIOL BLOOD LEVEL;
FEMALE;
FOLLITROPIN BLOOD LEVEL;
GROWTH HORMONE DEFICIENCY;
HORMONE SUBSTITUTION;
HUMAN;
HYDROCORTISONE BLOOD LEVEL;
HYPERGONADOTROPIC HYPOGONADISM;
HYPOGLYCEMIA;
IMPOTENCE;
LUTEINIZING HORMONE BLOOD LEVEL;
MAJOR CLINICAL STUDY;
MALE;
MENSTRUAL IRREGULARITY;
PAIN;
PRIORITY JOURNAL;
PROGESTERONE BLOOD LEVEL;
TESTOSTERONE BLOOD LEVEL;
|
EID: 17744370598
PISSN: 0021972X
EISSN: None
Source Type: Journal
DOI: 10.1210/jcem.85.6.6615 Document Type: Article |
Times cited : (418)
|
References (32)
|